These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32591278)

  • 1. Assessment of Malignancy Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT.
    Chai L; Zhu N; Wang Q; Wang T; Chai W
    Acad Radiol; 2021 May; 28(5):679-686. PubMed ID: 32591278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
    Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
    World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
    Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
    Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
    Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
    Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
    Pedrazzoli S; Sperti C; Pasquali C; Bissoli S; Chierichetti F
    Ann Surg; 2011 Dec; 254(6):971-6. PubMed ID: 22076067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas using MR findings and texture analysis.
    Jeon SK; Kim JH; Yoo J; Kim JE; Park SJ; Han JK
    Eur Radiol; 2021 May; 31(5):3394-3404. PubMed ID: 33140171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of each high-risk stigmata and worrisome features as a predictor of high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Pancreatology; 2020 Jul; 20(5):895-901. PubMed ID: 32624417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
    Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
    Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does PET with CT Have Clinical Utility in the Management of Patients with Intraductal Papillary Mucinous Neoplasm?
    Roch AM; Barron MR; Tann M; Sandrasegar K; Hannaford KN; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2015 Jul; 221(1):48-56. PubMed ID: 26095551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of magnetic resonance image for malignant intraductal papillary mucinous neoplasms: the importance of size of enhancing mural nodule within cyst.
    Hong SB; Lee NK; Kim S; Seo HI; Park YM; Noh BG; Kim DU; Han SY; Kim TU
    Jpn J Radiol; 2022 Dec; 40(12):1282-1289. PubMed ID: 35781178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.
    Do RK; Katz SS; Gollub MJ; Li J; LaFemina J; Zabor EC; Moskowitz CS; Klimstra DS; Allen PJ
    AJR Am J Roentgenol; 2014 Nov; 203(5):973-9. PubMed ID: 25341134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.
    Anand N; Sampath K; Wu BU
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):913-21; quiz e59-60. PubMed ID: 23416279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT findings and clinical effects of high grade pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms.
    Kim MC; Kim JH; Jeon SK; Kang HJ
    PLoS One; 2024; 19(4):e0298278. PubMed ID: 38683769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
    Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
    Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI.
    Min JH; Kim YK; Kim SK; Kim H; Ahn S
    Eur Radiol; 2021 Jul; 31(7):4774-4784. PubMed ID: 33409798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules.
    Ohno E; Hirooka Y; Itoh A; Ishigami M; Katano Y; Ohmiya N; Niwa Y; Goto H
    Ann Surg; 2009 Apr; 249(4):628-34. PubMed ID: 19300203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum elastase-1 predicts malignancy in intraductal papillary mucinous neoplasm of the pancreas.
    Mishima T; Takano S; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Hosokawa I; Konishi T; Nishino H; Nakada S; Kouchi Y; Kishimoto T; Ohtsuka M
    Pancreatology; 2024 Feb; 24(1):93-99. PubMed ID: 38102054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail.
    Zhou H; Li X; Wang Y; Wang Z; Zhu J; Wang Z; Chen X
    BMC Gastroenterol; 2022 Nov; 22(1):473. PubMed ID: 36402960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
    Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
    Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.